Apomorphine for prolonged disorders of consciousness: a multimodal open-label study
University and University Hospital of Liege, Belgian National Funds for Scientific Research, Fund Generet of the King Baudouin Foundation, AstraZeneca Foundation, Leon Fredericq Foundation and NeuroHealing Pharmaceuticals Inc.
Authors
- Johan Stender
- Rodrigo Huerta-Gutiérrez (ORCID: https://orcid.org/0000-0002-0882-9695)
- Nadia Dardenne (ORCID: https://orcid.org/0000-0001-5368-6059)
- Leandro Sanz (ORCID: https://orcid.org/0000-0001-5054-2471)
- Ross Zafonte (ORCID: https://orcid.org/0000-0002-1050-796X)
- Olivia Gosseries (ORCID: https://orcid.org/0000-0001-9011-7496)
- Arianna Sala (ORCID: https://orcid.org/0000-0001-8121-0891)
- Steven Laureys (ORCID: https://orcid.org/0000-0002-3096-3807)
- David Dikenstein
- Didier Ledoux (ORCID: https://orcid.org/0000-0002-9314-6564)
- Estelle Bonin (ORCID: https://orcid.org/0000-0002-5120-2767)
- Rajanikant Panda (ORCID: https://orcid.org/0000-0002-0960-4340)
- Neal Farber (ORCID: https://orcid.org/0000-0002-1182-6065)
- Roland Hustinx (ORCID: https://orcid.org/0000-0001-7164-8742)
- Aurore Thibaut (ORCID: https://orcid.org/0000-0001-5991-1747)
- Nicolas Lejeune (ORCID: https://orcid.org/0000-0001-6059-606X)
- Emilie Szymkowicz (ORCID: https://orcid.org/0000-0002-2247-515X)
- Nicholas D. Schiff (ORCID: https://orcid.org/0000-0003-0008-426X)
- Sébastien Van Goethem
Institutions
- University of Copenhagen (DK)
- Harvard University (US)
- University of Liège (BE)
- Cornell University (US)
- Spaulding Rehabilitation Hospital (US)
- MIND Research Institute (US)
- NeuroHealing Pharmaceuticals (United States) (US)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Centres Intégré Universitaires de Santé et de Services Sociaux (CA)
- Université Laval (CA)
- UCLouvain (BE)
- University of Lausanne (CH)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1016/j.eclinm.2024.102925
- Citations
- 10
- Primary Topic
- Traumatic Brain Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 3.87
Funders
- AstraZeneca
- AstraZeneca Foundation
- Koning Boudewijnstichting
- Fonds Léon Fredericq
- Britannia Pharmaceuticals